Zimmer Biomet Reports Growth to Close 2019

Indiana's medical device industry is widely known as one of the strongest in the world.

Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now

This audio file is brought to you by

0:00

0:00

Loading audio file, please wait.

Speed
1.00

• 0.25
• 0.50
• 0.75
• 1.00
• 1.25
• 1.50
• 1.75
• 2.00

Warsaw-based Zimmer Biomet Holdings Inc. (NYSE: ZBH) is reporting year-end net earnings of $1.1 billion, compared to a loss of $379 million the year prior.

Net earnings for the fourth quarter were $321 million, compared to a $901 million loss during the same period a year ago.

Zimmer Biomet, an orthopedic device maker in Kosciusko County, says it began several restructuring initiatives, including reorganizing business units to create greater strategic alignment.

“In 2019 we continued to successfully execute our plan to reposition the company for success, driven by our global team’s focus on our One ZB mission and culture,” said Bryan Hanson, president and chief executive officer of Zimmer Biomet.  “We continued to invest for growth and drove improved performance in 2019, especially in the second half of the year.”

Connect to the full earnings report by clicking here.